EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking the Potential of Carrier Mediated Nano‐biomedicine in Management of Diabetes Mellitus: A Review

Priya S Mistry, Sudarshan Singh iD, Mehul R Chorawala iD, Bhupendra G Prajapati iD, Devesh U Kapoor

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Priya S Mistry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacy Practice, L. M. College of Pharmacy, Opp. Gujarat University, Navrangpura, Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Drug Carriers, Hypoglycemic Agents, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 178 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a medical condition that belongs to the group of chronic diseases that affect how the body processes glucose, the primary source of energy for cells. Glucose comes indirectly from the consumed food and is carried by bloodstream to various cells in the body. Insulin, a hormone synthesized by the pancreas plays a vital role in the conversion of glucose to energy. Managing diabetes involves regular monitoring of blood sugar levels, adopting a healthy diet, engaging in regular physical activity, and taking medications or insulin as prescribed by a healthcare provider. Proper management of diabetes may lead to the prevention or delay of diabetic complications may further sever other diseases associated impediment. Drug delivery in the management of diabetes is designed to administer insulin or other diabetes medications in a controlled and convenient manner. Recently nanotechnology has emerged as a transformative approach in the management of diabetic complications, particularly through carrier‐mediated nano‐biomedicine. Several natural products have been studied and reported for their potential role in managing diabetes. While they may not replace standard medical treatments, some of these natural products could complement existing therapies and support overall diabetes management. Therefore, this review explores the potential of nanocarriers to enhance drug delivery systems for diabetes mellitus treatment, addressing the limitations of conventional therapies that often suffer from poor bioavailability and frequent dosing requirements. Studies have demonstrated that bridging these bioactive compounds significantly enhance the therapeutic efficacy in the management of diabetes. Challenges remain in translating these technologies from laboratory settings to clinical applications; however, the potential benefits for improving glycemic control and overall quality of life for diabetic patients are substantial. Future research should focus on optimizing these nano‐biomedicine strategies to realize their full therapeutic potential in diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDrug CarriersHypoglycemic AgentsNanoparticlesNanomedicineHumansDrug Delivery SystemsAnimalsInsulinBiological ProductsNanotechnology

Stichwörter der Autor:innen

bioactive compoundsdiabetesdrug delivery carriersnanomaterialnanomedicinenanotechnology

Substanzen

Drug CarriersHypoglycemic AgentsInsulinBiological Products

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacy Practice, L. M. College of Pharmacy, Opp. Gujarat University, Navrangpura, Ahmedabad, Gujarat, India.
  • Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand.
  • Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Shree S. K. Patel College of Pharmaceutical Education & Research, Ganpat University, Mehsana, Gujarat, India.
  • Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.
  • Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India.

ORCID-Profile: Sudarshan Singh, Mehul R Chorawala, Bhupendra G Prajapati

Zitieren

APA

Mistry, P. S., Singh, S., Chorawala, M. R., Prajapati, B. G., & Kapoor, D. U. (2025). Unlocking the Potential of Carrier Mediated Nano‐biomedicine in Management of Diabetes Mellitus: A Review. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402258

Vancouver

Mistry PS, Singh S, Chorawala MR, Prajapati BG, Kapoor DU. Unlocking the Potential of Carrier Mediated Nano‐biomedicine in Management of Diabetes Mellitus: A Review. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402258

BibTeX
@article{Mistry2025,
  author = {Mistry, Priya S and Singh, Sudarshan and Chorawala, Mehul R and Prajapati, Bhupendra G and Kapoor, Devesh U},
  title = {Unlocking the Potential of Carrier Mediated Nano‐biomedicine in Management of Diabetes Mellitus: A Review},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402258}
}
Kostenlos starten →